β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects

Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis

(2014) Konstantinos Toulis et al.   Hormones-International Journal of Endocrinology and Metabolism

β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients

(2012) Hong Ji Song et al.   BONE

Association between beta-blockers and fracture risk: A Bayesian meta-analysis

(2012) Shuman Yang et al.   BONE

The Relationship Among Hypertension, Antihypertensive Medications, and Osteoporosis: A Narrative Review

(2012) Katarina Ilić et al.   CALCIFIED TISSUE INTERNATIONAL

Deletion of β-adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation

(2012) Dominique D Pierroz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Heart Failure Is a Clinically and Densitometrically Independent Risk Factor for Osteoporotic Fractures: Population-Based Cohort Study of 45,509 Subjects

(2012) Sumit R. Majumdar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anabolic action of parathyroid hormone regulated by the  2-adrenergic receptor

(2012) R. Hanyu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acid suppressants and hip fracture: Duplicate publication bias?

(2011) Marloes Bazelier et al.   BONE

Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation

(2011) WF Rodrigues et al.   BRITISH JOURNAL OF PHARMACOLOGY

β2-Adrenergic Receptor Signaling in Osteoblasts Contributes to the Catabolic Effect of Glucocorticoids on Bone

(2011) Yun Ma et al.   ENDOCRINOLOGY

Risk of fractures in older adults using antihypertensive medications

(2011) Daniel H Solomon et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sympathetic control of bone mass regulated by osteopontin

(2011) M. Nagao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association between beta-blocker use and fracture risk: The Dubbo Osteoporosis Epidemiology Study

(2010) Shuman Yang et al.   BONE

Continuous Treatment with a Low-Dose β-Agonist Reduces Bone Mass by Increasing Bone Resorption Without Suppressing Bone Formation

(2010) Hisataka Kondo et al.   CALCIFIED TISSUE INTERNATIONAL

Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci

(2009) Munro Peacock et al.   BONE

Race and sex differences in bone mineral density and geometry at the femur

(2009) M. Peacock et al.   BONE

Regulation of bone remodeling by the central and peripheral nervous system

(2008) Florent Elefteriou   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

β2-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms

(2008) Sarah J. Aitken et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Molecular bases of the sympathetic regulation of bone mass

(2008) Shu Takeda et al.   BONE

Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions

(2008) N. Bonnet et al.   JOURNAL OF CELLULAR PHYSIOLOGY